Staying active helps fight fatigue, but it's important to ease into exercise while on GLP-1 medications
Researchers who have been tracking the semaglutide versus tirzepatide comparison will recognize that CagriSema fundamentally changes the competitive landscape by adding amylin to the equation
Putative mechanisms of tirzepatide-mediated nephroprotection The pathogenesis of CKD in patients with T2D likely involves other potential contributors besides hyperglycemia, such as hypertension, dyslipidemia, obesity, insulin resistance, glomerular atherosclerosis, renal ischemia, and nephron aging [53]
IPAA, Ileal pouch-anal anastomosis
The oral segment is projected to witness the fastest CAGR from 2025 to 2032, driven by the growing demand for needle-free alternatives and the launch of oral GLP-1 receptor agonists such as Rybelsus (oral semaglutide) and future pipeline products such as orforglipron